Asked by: Jack Brereton (Conservative - Stoke-on-Trent South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the (a) UK’s vaccine vial production capability, (b) reliance of the UK on the import of medical grade vials and (c) security of UK supply chains in the event of a future pandemic.
Answered by Maria Caulfield
The Department for Business and Trade has not conducted assessments on these specific goods. The Government has established strategic partnerships with industry to maintain security of vaccine supply in the event of a pandemic. This includes our partnership with Moderna which is building an innovation and technology centre with capacity from 2025 to produce up to 250 million doses of mRNA vaccines annually onshore in the United Kingdom.
The UK Health Security Agency has also agreed an advanced purchase agreement with Seqirus UK Limited to access 100 million vaccines if a future influenza pandemic is declared. The manufacturing process will be based entirely in the UK, giving better security of access if global demand ever outweighs supply. As part of these contracts, the Government regularly assesses risks that may impact the performance of the contract.
Asked by: Jack Brereton (Conservative - Stoke-on-Trent South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the (a) adequacy of the UK’s vaccine vial production capability, (b) reliance of the UK on the import of medical grade vials and (c) security of UK supply chains in the event of a future pandemic.
Answered by Maria Caulfield
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Asked by: Jack Brereton (Conservative - Stoke-on-Trent South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to roll out the implantable cardiac monitoring commissioning system used in Staffordshire and Stoke-on-Trent to other Integrated Care Boards in England.
Answered by Will Quince
Implantable cardiac monitors are used successfully by patients across England and within the Stoke-on-Trent South constituency. The National Institute for Health and Care Excellence published guidance in September 2020 on the use of implantable cardiac monitors. National Health Service trusts are currently using such devices in stroke prevention throughout England. It is for local integrated care systems to determine the appropriate cardiac monitoring devices for their populations’ commissioners.
Asked by: Jack Brereton (Conservative - Stoke-on-Trent South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to implantable cardiac monitors in (a) England and (b) Stoke-on-Trent South constituency.
Answered by Will Quince
Implantable cardiac monitors are used successfully by patients across England and within the Stoke-on-Trent South constituency. The National Institute for Health and Care Excellence published guidance in September 2020 on the use of implantable cardiac monitors. National Health Service trusts are currently using such devices in stroke prevention throughout England. It is for local integrated care systems to determine the appropriate cardiac monitoring devices for their populations’ commissioners.
Asked by: Jack Brereton (Conservative - Stoke-on-Trent South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to use implantable cardiac monitoring for secondary stroke prevention in the NHS.
Answered by Will Quince
Implantable cardiac monitors are used successfully by patients across England and within the Stoke-on-Trent South constituency. The National Institute for Health and Care Excellence published guidance in September 2020 on the use of implantable cardiac monitors. National Health Service trusts are currently using such devices in stroke prevention throughout England. It is for local integrated care systems to determine the appropriate cardiac monitoring devices for their populations’ commissioners.